Physician

Charlene A Ives, MD

According to 2025 Medicare claims, Charlene Ives, MD (NPI: 1548286362) practices medical oncology in the Albany-Schenectady-Troy, NY market, with the plurality of this provider's patient population coming from Rensselaer, NY. This provider's primary affiliated billing organization is NEW YORK ONCOLOGY HEMATOLOGY, P.C. (NPI: 1609863448; TIN: 141799724) and primary practice location at 12180-2450.

Ives' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 300 traditional Medicare patients, billed 82,898 HCPCS/CPT codes, and received $1,370,020 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 532 prescription claims across 112 beneficiaries totaling $749,008 in drug costs, led by Imbruvica (Ibrutinib). 2022 DME data shows 22 claims. Open Payments data shows 1 records totaling $21. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $89,689 to $1,370,020. In contrast, Part D prescription costs have fallen sharply in recent years, from $523,424 to $749,008. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$685K$1.4M2015 Medicare payment: $89,689 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $108,606 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $111,019 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $96,590 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $67,166 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $70,272 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $93,466 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $284,134 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,021,419 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,370,020 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20154961,543$89,689
20165261,656$108,606
20175361,690$111,019
20185501,535$96,590
20194291,142$67,166
20204931,113$70,272
20214151,033$93,466
202227917,138$284,134
202333072,401$1,021,419
202430082,898$1,370,020

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.6M$3.3M2015 Drug cost: $523,424 (USD; Tot_Drug_Cst)2016 Drug cost: $1,004,092 (USD; Tot_Drug_Cst)2017 Drug cost: $1,408,224 (USD; Tot_Drug_Cst)2018 Drug cost: $2,034,235 (USD; Tot_Drug_Cst)2019 Drug cost: $3,277,657 (USD; Tot_Drug_Cst)2020 Drug cost: $3,256,230 (USD; Tot_Drug_Cst)2021 Drug cost: $2,468,129 (USD; Tot_Drug_Cst)2022 Drug cost: $845,307 (USD; Tot_Drug_Cst)2023 Drug cost: $532,734 (USD; Tot_Drug_Cst)2024 Drug cost: $749,008 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015141772$523,424
2016149870$1,004,092
2017170945$1,408,224
2018158740$2,034,235
2019173900$3,277,657
2020169807$3,256,230
2021151610$2,468,129
2022117424$845,307
2023110497$532,734
2024112532$749,008

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$3.4K$6.9K2015 Medicare payment: $2,268 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $634 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $592 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $4,664 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $6,887 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $5,233 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $2,975 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R89$2,268
2016N/R12$634
2017N/R12$592
2018N/RN/RN/R
2019N/R27$4,664
2020N/R83$6,887
2021N/R42$5,233
2022N/R22$2,975
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more111189$89
80053Blood test, comprehensive group of blood chemicals159385$10
36415Insertion of needle into vein for collection of blood sample189467$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count180495$8
83615Lactate dehydrogenase (enzyme) level114192$6

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
ImbruvicaIbrutinib16448$259,266
KisqaliRibociclib Succinate13364$186,179
EliquisApixaban361,594$29,992
XareltoRivaroxaban14420$7,852
AnastrozoleAnastrozole947,566$1,706

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$21Novartis Pharmaceuticals Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Charlene A. Ives, MD?

Tedicare shows public-source Medicare data for Charlene A. Ives, MD (NPI 1548286362), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Charlene A. Ives, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Charlene A. Ives, MD?

Charlene A. Ives, MD is linked to NEW YORK ONCOLOGY HEMATOLOGY, P.C. (billing NPI 1609863448) in the available physician profile data.

Does Charlene A. Ives, MD have Open Payments data?

Charlene A. Ives, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.